13F HOLDINGS REPORT
GENERAL ATLANTIC, L.P.
Quarter ended Q3 2024 · Filed November 12, 2024 · Accession 0000950142-24-002746
Total Value
$3.52B
Positions
18
Other Managers
0
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ALIGNMENT HEALTHCARE | ALHC | 60,993,323 | $720.9M | 20.50% |
| 2 | XP, INC | XP | 29,617,733 | $531.3M | 15.11% |
| 3 | DLOCAL | DLO | 63,906,695 | $511.3M | 14.53% |
| 4 | SQUARESPACE | 85225A107 | 10,611,073 | $492.7M | 14.01% |
| 5 | ALKAMI | ALKT | 15,520,318 | $489.5M | 13.92% |
| 6 | CENTESSA PHARMACEUTICALS | CNTA | 9,681,818 | $154.8M | 4.40% |
| 7 | AKERO THERAPEUTICS | 00973Y108 | 5,233,989 | $150.2M | 4.27% |
| 8 | PHARVARIS | PHVS | 7,531,252 | $139.5M | 3.97% |
| 9 | EUROPEAN WAX CENTER | 29882P106 | 13,110,492 | $89.2M | 2.53% |
| 10 | BLEND LABS | BLND | 19,132,440 | $71.7M | 2.04% |
| 11 | ROYALTY PHARMA | RPRX | 1,500,000 | $42.4M | 1.21% |
| 12 | THIRD HARMONIC BIO | 88427A107 | 2,958,762 | $40.1M | 1.14% |
| 13 | IMMUNOCORE | IMCR | 1,261,684 | $39.3M | 1.12% |
| 14 | RISKIFIED | RSKD | 5,324,998 | $25.2M | 0.72% |
| 15 | ACELYRIN | 00445A100 | 2,889,668 | $14.2M | 0.41% |
| 16 | WISH | LOGC | 609,616 | $3.3M | 0.09% |
| 17 | GROVE COLLABORATIVE | GROVW | 936,020 | $1.3M | 0.04% |
| 18 | ADAGENE | ADAG | 264,000 | $586,080 | 0.02% |